Patent No. 602571 Disclosed is the use of an effective amount of miR-145 in the manufacture of a medicament for the treatment of muscle injury in a subject. Also disclosed is an in vitro method for modulating myocyte differentiation, proliferation, or both, comprising contacting a myocyte with an inhibitor of miR-145.